Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-015471

SVP and General Counsel sold 2,812 shares at an average $55.53 ($156,138)

  • SVP and General Counsel acquired 2,812 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-26 Exercise or conversion : show line 1 in the form +1,041 $7.80 $8,120 2,341 D
2021-02-26 Exercise or conversion : show line 2 in the form +1,771 $6.55 $11,600 4,112 D
2021-02-26 Sale : show line 3 in the form −1,079 $54.47 $58,773 3,033 D
2021-02-26 Sale : show line 4 in the form −400 $55.46 $22,184 2,633 D
2021-02-26 Sale : show line 5 in the form −1,333 $56.40 $75,181 1,300 D
Open-market sales · 2,812 sh · avg $55.53 · $156,138

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-26 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −1,041 27,084 D
2021-02-26 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −1,771 23,021 D
Loading xslF345X03/doc4.xml…